Loading…
Biogen intends to invest an additional $2 billion in its existing manufacturing footprint in North Carolina's Research Triangle Park, expanding ASO capabilities and adding fill-finish capacity.
“With this investment, we will modernize and expand our manufacturing capability to enable our pipeline and provide resilient patient supply, while continuing to support the skilled and dedicated community of life sciences talent in North Carolina.”investors.biogen.com
Summarized from public sources; check the original articles before acting on it.